Retinoblastoma rising among Indian children: AIIMS

Image
IANS New Delhi
Last Updated : May 14 2015 | 7:02 PM IST

Retinoblastoma, a rare type of eye cancer, is a fast emerging disease among Indian children, leading eye specialists at the All India Institute of Medical Sciences (AIIMS) said here on Thursday.

They averred that though earlier the disease used to occur 1 in 20,000 live births but now the rise in the disease is such that every year over 20,000 new cases of retinoblastoma are being witnessed.

The opthalmologists stated that late diagnosis and misconceptions about the symptoms were the major reasons that the eye cancer even extended to the brain and then to the entire body, ultimately leaving no option of treatment for the patients.

"Retinoblastoma basically occurs among children below five years. This can be caused both genetically and non-genetically. The problem with Indian children is that due to lack of awareness the parents bring their children only after observing any thing major in the eyes of their children," said Bhavana Chawla, associate professor at RP Centre for Ophthalmic Sciences at AIIMS.

She was speaking to reporters during a discussion at AIIMS on the rise of retinoblastoma.

Noting that many people in India didn't recognise the symptoms of eye cancer due to lack of awareness, Chawla said that any patient with a white spot in the eye, squint or any type of shine in the eye balls should come and get tested for retinoblastoma.

She also said that in many cases it becomes difficult for doctors to save the eye sight which gets majorly affected during the disease.

Professor Pradeep Sharma at RP centre said that the major problem with Indians suffering from retinoblastoma is that they approach the doctors at a very late stage even though India has made some of the finest medical advancements in treating eye cancer.

"Treatments like surgery, laser surgery, chemotherapy with perfect effect are the only way to cure the disease. The situation is such that currently it is not possible to save the eyesight of the patient after the surgery, however research is on to make it possible," Sharma told IANS.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 14 2015 | 6:52 PM IST

Next Story